-
1
-
-
84991244889
-
AME evidence series 001-The Society for Translational Medicine: clinical practice guidelines for diagnosis and early identification of sepsis in the hospital
-
Zhang, Z. et al. AME evidence series 001-The Society for Translational Medicine: clinical practice guidelines for diagnosis and early identification of sepsis in the hospital. J Thorac Dis 8, 2654–2665 (2016)
-
(2016)
J Thorac Dis
, vol.8
, pp. 2654-2665
-
-
Zhang, Z.1
-
2
-
-
85013468576
-
Epidemiology of sepsis in Catalonia: analysis of incidence and outcomes in a European setting
-
Yébenes, J. C. et al. Epidemiology of sepsis in Catalonia: analysis of incidence and outcomes in a European setting. Ann Intensive Care 7, 19 (2017)
-
(2017)
Ann Intensive Care
, vol.7
-
-
Yébenes, J.C.1
-
3
-
-
84873714375
-
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012
-
COI: 1:STN:280:DC%2BC3szjs1Witw%3D%3D
-
Dellinger, R. P. et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive care medicine 39, 165–228 (2013)
-
(2013)
Intensive care medicine
, vol.39
, pp. 165-228
-
-
Dellinger, R.P.1
-
4
-
-
85014121208
-
Early management of sepsis with emphasis on early goal directed therapy: AME evidence series 002
-
Zhang, Z. et al. Early management of sepsis with emphasis on early goal directed therapy: AME evidence series 002. J Thorac Dis 9, 392–405 (2017)
-
(2017)
J Thorac Dis
, vol.9
, pp. 392-405
-
-
Zhang, Z.1
-
5
-
-
84979197941
-
The Japanese guidelines for the management of sepsis
-
Oda, S. et al. The Japanese guidelines for the management of sepsis. J Intensive Care 2, 55 (2014)
-
(2014)
J Intensive Care
, vol.2
-
-
Oda, S.1
-
6
-
-
84925535576
-
Effectiveness of treatment based on PiCCO parameters in critically ill patients with septic shock and/or acute respiratory distress syndrome: a randomized controlled trial
-
COI: 1:CAS:528:DC%2BC2MXhs1alu74%3D
-
Zhang, Z., Ni, H. & Qian, Z. Effectiveness of treatment based on PiCCO parameters in critically ill patients with septic shock and/or acute respiratory distress syndrome: a randomized controlled trial. Intensive Care Med 41, 444–451 (2015)
-
(2015)
Intensive Care Med
, vol.41
, pp. 444-451
-
-
Zhang, Z.1
Ni, H.2
Qian, Z.3
-
7
-
-
0034958947
-
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
-
COI: 1:STN:280:DC%2BD3Mvgs12gtg%3D%3D
-
Angus, D. C. et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303–1310 (2001)
-
(2001)
Crit. Care Med.
, vol.29
, pp. 1303-1310
-
-
Angus, D.C.1
-
8
-
-
84956616365
-
Sepsis-induced immune dysfunction: can immune therapies reduce mortality?
-
Delano, M. J. & Ward, P. A. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J. Clin. Invest. 126, 23–31 (2016)
-
(2016)
J. Clin. Invest.
, vol.126
, pp. 23-31
-
-
Delano, M.J.1
Ward, P.A.2
-
9
-
-
84962580213
-
Ulinastatin-a newer potential therapeutic option for multiple organ dysfunction syndrome
-
COI: 1:CAS:528:DC%2BC28XktFGmtbk%3D
-
Atal, S. S. & Atal, S. Ulinastatin-a newer potential therapeutic option for multiple organ dysfunction syndrome. J Basic Clin Physiol Pharmacol 27, 91–99 (2016)
-
(2016)
J Basic Clin Physiol Pharmacol
, vol.27
, pp. 91-99
-
-
Atal, S.S.1
Atal, S.2
-
10
-
-
85012048367
-
Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells
-
COI: 1:CAS:528:DC%2BC1cXivVehs7w%3D
-
Luo, Y., Che, W. & Zhao, M. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells. International Journal of Molecular Medicine 39, 297–306 (2017)
-
(2017)
International Journal of Molecular Medicine
, vol.39
, pp. 297-306
-
-
Luo, Y.1
Che, W.2
Zhao, M.3
-
11
-
-
84957430576
-
Ulinastatin and/or thymosin α1 for severe sepsis: A systematic review and meta-analysis
-
Feng, Z., Shi, Q., Fan, Y., Wang, Q. & Yin, W. Ulinastatin and/or thymosin α1 for severe sepsis: A systematic review and meta-analysis. J Trauma Acute Care Surg 80, 335–340 (2016)
-
(2016)
J Trauma Acute Care Surg
, vol.80
, pp. 335-340
-
-
Feng, Z.1
Shi, Q.2
Fan, Y.3
Wang, Q.4
Yin, W.5
-
12
-
-
85008655979
-
Effect of ulinastatin combined with thymosin alpha1 on sepsis: A systematic review and meta-analysis of Chinese and Indian patients
-
COI: 1:CAS:528:DC%2BC2sXmsVyjtg%3D%3D
-
Liu, D. et al. Effect of ulinastatin combined with thymosin alpha1 on sepsis: A systematic review and meta-analysis of Chinese and Indian patients. J Crit Care 39, 259–266 (2017)
-
(2017)
J Crit Care
, vol.39
, pp. 259-266
-
-
Liu, D.1
-
13
-
-
85053816598
-
Ulinastatin did not reduce mortality in elderly multiple organ failure patients: a retrospective observational study in a single center ICU
-
Uchida, M., Abe, T., Ono, K. & Tamiya, N. Ulinastatin did not reduce mortality in elderly multiple organ failure patients: a retrospective observational study in a single center ICU. Acute Med Surg 5, 90–97 (2018)
-
(2018)
Acute Med Surg
, vol.5
, pp. 90-97
-
-
Uchida, M.1
Abe, T.2
Ono, K.3
Tamiya, N.4
-
15
-
-
0022256529
-
APACHE II: A severity of disease classification system
-
COI: 1:STN:280:DyaL2M3otlyqtQ%3D%3D
-
Knaus, W. A., Draper, E. A., Wagner, D. P. & Zimmerman, J. E. APACHE II: A severity of disease classification system. Crit. Care Med. 13, 818–829 (1985)
-
(1985)
Crit. Care Med.
, vol.13
, pp. 818-829
-
-
Knaus, W.A.1
Draper, E.A.2
Wagner, D.P.3
Zimmerman, J.E.4
-
16
-
-
60849102446
-
Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review
-
Minne, L., Abu-Hanna, A. & de Jonge, E. Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review. Crit Care 12, R161 (2008)
-
(2008)
Crit Care
, vol.12
-
-
Minne, L.1
Abu-Hanna, A.2
de Jonge, E.3
-
17
-
-
85006201765
-
Univariate description and bivariate statistical inference: the first step delving into data
-
Zhang, Z. Univariate description and bivariate statistical inference: the first step delving into data. Ann Transl Med 4, 91–91 (2016)
-
(2016)
Ann Transl Med
, vol.4
, pp. 91
-
-
Zhang, Z.1
-
18
-
-
85037994457
-
Comparing baseline characteristics between groups: an introduction to the CBCgrps package
-
Zhang, Z., Gayle, A. A., Wang, J., Zhang, H. & Cardinal-Fernández, P. Comparing baseline characteristics between groups: an introduction to the CBCgrps package. Ann Transl Med 5, 484–484 (2017)
-
(2017)
Ann Transl Med
, vol.5
, pp. 484
-
-
Zhang, Z.1
Gayle, A.A.2
Wang, J.3
Zhang, H.4
Cardinal-Fernández, P.5
-
19
-
-
85006198872
-
Model building strategy for logistic regression: purposeful selection
-
Zhang, Z. Model building strategy for logistic regression: purposeful selection. Ann Transl Med 4, 111–111 (2016)
-
(2016)
Ann Transl Med
, vol.4
, pp. 111
-
-
Zhang, Z.1
-
20
-
-
85006189450
-
Causal mediation analysis in the context of clinical research
-
Zhang, Z. et al. Causal mediation analysis in the context of clinical research. Ann Transl Med 4, 425–425 (2016)
-
(2016)
Ann Transl Med
, vol.4
, pp. 425
-
-
Zhang, Z.1
-
21
-
-
78650085125
-
A General Approach to Causal Mediation Analysis
-
Imai, K., Keele, L. & Tingley, D. A General Approach to Causal Mediation Analysis. Psychological Methods 15, 309–334 (2010)
-
(2010)
Psychological Methods
, vol.15
, pp. 309-334
-
-
Imai, K.1
Keele, L.2
Tingley, D.3
-
22
-
-
85044519098
-
Role of Ulinastatin, a trypsin inhibitor, in severe acute pancreatitis in critical care setting: A retrospective analysis
-
COI: 1:CAS:528:DC%2BC1cXitFyiu74%3D
-
Lagoo, J. Y., D’Souza, M. C., Kartha, A. & Kutappa, A. M. Role of Ulinastatin, a trypsin inhibitor, in severe acute pancreatitis in critical care setting: A retrospective analysis. J Crit Care 45, 27–32 (2018)
-
(2018)
J Crit Care
, vol.45
, pp. 27-32
-
-
Lagoo, J.Y.1
D’Souza, M.C.2
Kartha, A.3
Kutappa, A.M.4
-
23
-
-
84901476727
-
Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: A multicenter randomized controlled study
-
COI: 1:CAS:528:DC%2BC2cXmsFaktLY%3D
-
Karnad, D. R. et al. Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: A multicenter randomized controlled study. Intensive Care Med 40, 830–838 (2014)
-
(2014)
Intensive Care Med
, vol.40
, pp. 830-838
-
-
Karnad, D.R.1
-
24
-
-
84881148392
-
Efficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with mild or severe acute pancreatitis
-
PID: 24818336
-
Abraham, P. et al. Efficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with mild or severe acute pancreatitis. J Assoc Physicians India 61, 535–538 (2013)
-
(2013)
J Assoc Physicians India
, vol.61
, pp. 535-538
-
-
Abraham, P.1
-
25
-
-
84887416628
-
The effect of ulinastatin on disbalance of inflammation and immune status in patients with severe sepsis
-
COI: 1:CAS:528:DC%2BC2cXitFGlt7nN, PID: 23660098
-
Wu, T.-J., Zhang, L.-N. & Kang, C.-C. The effect of ulinastatin on disbalance of inflammation and immune status in patients with severe sepsis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 25, 219–223 (2013)
-
(2013)
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
, vol.25
, pp. 219-223
-
-
Wu, T.-J.1
Zhang, L.-N.2
Kang, C.-C.3
-
26
-
-
85042420359
-
ADJunctive Ulinastatin in Sepsis Treatment in China (ADJUST study): study protocol for a randomized controlled trial
-
Jiang, W. et al. ADJunctive Ulinastatin in Sepsis Treatment in China (ADJUST study): study protocol for a randomized controlled trial. Trials 19, 133 (2018)
-
(2018)
Trials
, vol.19
-
-
Jiang, W.1
-
27
-
-
85014242260
-
Application of the Third International Consensus Definitions for Sepsis (Sepsis-3) Classification: a retrospective population-based cohort study
-
Donnelly, J. P., Safford, M. M., Shapiro, N. I., Baddley, J. W. & Wang, H. E. Application of the Third International Consensus Definitions for Sepsis (Sepsis-3) Classification: a retrospective population-based cohort study. Lancet Infect Dis 17, 661–670 (2017)
-
(2017)
Lancet Infect Dis
, vol.17
, pp. 661-670
-
-
Donnelly, J.P.1
Safford, M.M.2
Shapiro, N.I.3
Baddley, J.W.4
Wang, H.E.5
-
28
-
-
85017203611
-
Impact of Ulinastatin on Outcomes in Acute Burns Patients
-
Abhyankar, S. V. & Vartak, A. M. Impact of Ulinastatin on Outcomes in Acute Burns Patients. J Burn Care Res 1 https://doi.org/10.1097/BCR.0000000000000546 (2017)
-
(2017)
J Burn Care Res
, vol.1
-
-
Abhyankar, S.V.1
Vartak, A.M.2
-
29
-
-
85020123692
-
Clinical value of the early use of ulinastatin in patients with moderately severe or severe acute pancreatitis
-
COI: 1:STN:280:DC%2BC1crhtVGhsw%3D%3D, PID: 28441856
-
Wang, J. et al. Clinical value of the early use of ulinastatin in patients with moderately severe or severe acute pancreatitis. Zhonghua Yi Xue Za Zhi 97, 1252–1255 (2017)
-
(2017)
Zhonghua Yi Xue Za Zhi
, vol.97
, pp. 1252-1255
-
-
Wang, J.1
-
30
-
-
85042739879
-
Effects of ulinastatin on inflammatory response and cognitive function after hip arthroplasty for the elderly patients with femoral neck fracture
-
PID: 29509266
-
Ren, K.-W., Shen, N., Tang, J.-L., Nong, L.-M. & Gu, Y.-Q. Effects of ulinastatin on inflammatory response and cognitive function after hip arthroplasty for the elderly patients with femoral neck fracture. Eur Rev Med Pharmacol Sci 22, 1126–1132 (2018)
-
(2018)
Eur Rev Med Pharmacol Sci
, vol.22
, pp. 1126-1132
-
-
Ren, K.-W.1
Shen, N.2
Tang, J.-L.3
Nong, L.-M.4
Gu, Y.-Q.5
-
31
-
-
85043402743
-
Influences of ulinastatin on acute lung injury and time phase changes of coagulation parameters in rats with burn-blast combined injuries
-
COI: 1:STN:280:DC%2BC1MvkvVShsw%3D%3D, PID: 29374925
-
Liu, W. & Chai, J. K. Influences of ulinastatin on acute lung injury and time phase changes of coagulation parameters in rats with burn-blast combined injuries. Zhonghua Shao Shang Za Zhi 34, 32–39 (2018)
-
(2018)
Zhonghua Shao Shang Za Zhi
, vol.34
, pp. 32-39
-
-
Liu, W.1
Chai, J.K.2
-
32
-
-
85053828548
-
Ulinastatin Protects Against LPS-Induced Acute Lung Injury by Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators
-
Cao, C. et al. Ulinastatin Protects Against LPS-Induced Acute Lung Injury by Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators. Shock 1, 10.1097/SHK.0000000000001104 (2018)
-
(2018)
Shock
, vol.1
-
-
Cao, C.1
-
33
-
-
85051427510
-
Ulinastatin attenuates LPS-induced inflammation in mouse macrophageRAW264.7 cells by inhibiting the JNK/NF-κB signaling pathway and activating the PI3K/Akt/Nrf2 pathway
-
Li, S.-T. et al. Ulinastatin attenuates LPS-induced inflammation in mouse macrophageRAW264.7 cells by inhibiting the JNK/NF-κB signaling pathway and activating the PI3K/Akt/Nrf2 pathway. Acta Pharmacol. Sin. 8, 41988 (2018)
-
(2018)
Acta Pharmacol. Sin.
, vol.8
, pp. 41988
-
-
Li, S.-T.1
-
34
-
-
85051205267
-
Ulinastatin inhibits high glucose-induced cardiomyocyte apoptosis through activating Akt signaling
-
COI: 1:STN:280:DC%2BB3c7jt1ahsQ%3D%3D, PID: 30058707
-
Long, Y., Zhang, Y., Cai, S.-S., Sun, D.-M. & Li, Y.-H. Ulinastatin inhibits high glucose-induced cardiomyocyte apoptosis through activating Akt signaling. Eur Rev Med Pharmacol Sci 22, 4691–4697 (2018)
-
(2018)
Eur Rev Med Pharmacol Sci
, vol.22
, pp. 4691-4697
-
-
Long, Y.1
Zhang, Y.2
Cai, S.-S.3
Sun, D.-M.4
Li, Y.-H.5
-
35
-
-
85042120456
-
Endothelial Glycocalyx Layer: A Possible Therapeutic Target for Acute Lung Injury during Lung Resection
-
PID: 29423410
-
Wang, J., Wu, A. & Wu, Y. Endothelial Glycocalyx Layer: A Possible Therapeutic Target for Acute Lung Injury during Lung Resection. Biomed Res Int 2017, 5969657–8 (2017)
-
(2017)
Biomed Res Int
, vol.2017
, pp. 5969657-5969658
-
-
Wang, J.1
Wu, A.2
Wu, Y.3
-
36
-
-
85053821297
-
Ulinastatin attenuates hyper-permeability of vascular endothelialium cells induced by serum from patients with sepsis
-
PID: 29382417
-
Liu, S. et al. Ulinastatin attenuates hyper-permeability of vascular endothelialium cells induced by serum from patients with sepsis. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 33, 1600–1604 (2017)
-
(2017)
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
, vol.33
, pp. 1600-1604
-
-
Liu, S.1
-
37
-
-
85041107320
-
Xuebijing combined with ulinastation benefits patients with sepsis: A meta-analysis
-
Zheng, J. et al. Xuebijing combined with ulinastation benefits patients with sepsis: A meta-analysis. Am J Emerg Med 36, 480–487 (2018)
-
(2018)
Am J Emerg Med
, vol.36
, pp. 480-487
-
-
Zheng, J.1
|